Tobira Therapeutics

Tobira Therapeutics

Princeton, N.J.
Founder: Dr. Eckard Weber
VC Investment over the last four quarters: $30 million

Founded in 2006, nine-employee biotech company Tobira is focusing on developing and commercializing treatments for infectious diseases, including HIV. The company, which was issued a U.S. patent in August for an antiviral compound, is proceeding with its proof of concept study "to demonstrate safety and efficacy in HIV positive patients," says CEO James Sapirstein.

Key to startup success: N/A